245 related articles for article (PubMed ID: 16000041)
1. Anthrax countermeasures: current status and future needs.
Borio LL; Gronvall GK
Biosecur Bioterror; 2005; 3(2):102-12. PubMed ID: 16000041
[TBL] [Abstract][Full Text] [Related]
2. Medical countermeasures to protect humans from anthrax bioterrorism.
Bouzianas DG
Trends Microbiol; 2009 Nov; 17(11):522-8. PubMed ID: 19781945
[TBL] [Abstract][Full Text] [Related]
3. Project BioShield: what it is, why it is needed, and its accomplishments so far.
Russell PK
Clin Infect Dis; 2007 Jul; 45 Suppl 1():S68-72. PubMed ID: 17582574
[TBL] [Abstract][Full Text] [Related]
4. Bioterrorism watch. Anthrax aftermath: adverse drug reactions, vaccine controversy undercut CDC extended treatment offer.
Evans G
Hosp Peer Rev; 2002 Mar; 27(3):suppl 1-4. PubMed ID: 11905387
[No Abstract] [Full Text] [Related]
5. Modeling the logistics of response to anthrax bioterrorism.
Zaric GS; Bravata DM; Cleophas Holty JE; McDonald KM; Owens DK; Brandeau ML
Med Decis Making; 2008; 28(3):332-50. PubMed ID: 18349432
[TBL] [Abstract][Full Text] [Related]
6. Vaccines and bioterrorism: smallpox and anthrax.
Kimmel SR; Mahoney MC; Zimmerman RK
J Fam Pract; 2003 Jan; 52(1 Suppl):S56-61. PubMed ID: 12556279
[TBL] [Abstract][Full Text] [Related]
7. U.S. medical countermeasure development since 2001: a long way yet to go.
Russell PK; Gronvall GK
Biosecur Bioterror; 2012 Mar; 10(1):66-76. PubMed ID: 22455680
[TBL] [Abstract][Full Text] [Related]
8. The mayor, his troops, and the health of a city.
Tully S
Fortune; 2001 Nov; 144(11):138-42. PubMed ID: 11816774
[No Abstract] [Full Text] [Related]
9. Anthrax vaccines: present status and future prospects.
Kaur M; Singh S; Bhatnagar R
Expert Rev Vaccines; 2013 Aug; 12(8):955-70. PubMed ID: 23984963
[TBL] [Abstract][Full Text] [Related]
10. Responding to a small-scale bioterrorist anthrax attack: cost-effectiveness analysis comparing preattack vaccination with postattack antibiotic treatment and vaccination.
Schmitt B; Dobrez D; Parada JP; Kyriacou DN; Golub RM; Sharma R; Bennett C
Arch Intern Med; 2007 Apr; 167(7):655-62. PubMed ID: 17420423
[TBL] [Abstract][Full Text] [Related]
11. Pediatric anthrax clinical management: executive summary.
Bradley JS; Peacock G; Krug SE; Bower WA; Cohn AC; Meaney-Delman D; Pavia AT;
Pediatrics; 2014 May; 133(5):940-2. PubMed ID: 24777221
[No Abstract] [Full Text] [Related]
12. Anthrax aftermath: adverse drug reactions, vaccine controversy undercut CDC extended treatment offer.
Evans G
ED Manag; 2002 Mar; 14(3):suppl 1-4. PubMed ID: 11912887
[No Abstract] [Full Text] [Related]
13. [Evaluation of anthrax vaccination in Denmark].
Bork KH; Heegaard ED; Nielsen J; Kogutowska E; Heegaard NH
Ugeskr Laeger; 2005 Sep; 167(36):3390-3. PubMed ID: 16159489
[TBL] [Abstract][Full Text] [Related]
14. Blinded by bioterrorism: public health and liberty in the 21st century.
Annas GJ
Health Matrix Clevel; 2003; 13(1):33-70. PubMed ID: 14569657
[No Abstract] [Full Text] [Related]
15. Reducing mortality from anthrax bioterrorism: strategies for stockpiling and dispensing medical and pharmaceutical supplies.
Bravata DM; Zaric GS; Holty JE; Brandeau ML; Wilhelm ER; McDonald KM; Owens DK
Biosecur Bioterror; 2006; 4(3):244-62. PubMed ID: 16999586
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of public health interventions for Anthrax: a report to the secretary's council on Public Health Preparedness.
Wein LM; Craft DL;
Biosecur Bioterror; 2005; 3(4):348-56. PubMed ID: 16366844
[TBL] [Abstract][Full Text] [Related]
17. HEPA/vaccine plan for indoor anthrax remediation.
Wein LM; Liu Y; Leighton TJ
Emerg Infect Dis; 2005 Jan; 11(1):69-76. PubMed ID: 15705325
[TBL] [Abstract][Full Text] [Related]
18. Implementing the cities readiness initiative: lessons learned from Boston.
Koh HK; Elqura LJ; Judge CM; Jacob JP; Williams AE; Crowther MS; Serino RA; Auerbach JM
Disaster Med Public Health Prep; 2008 Mar; 2(1):40-9. PubMed ID: 18388657
[TBL] [Abstract][Full Text] [Related]
19. Anthrax vaccine and public health policy.
Weiss MM; Weiss PD; Weiss JB
Am J Public Health; 2007 Nov; 97(11):1945-51. PubMed ID: 17901434
[TBL] [Abstract][Full Text] [Related]
20. Anthrax prevention and treatment.
FDA Consum; 2001; 35(6):9. PubMed ID: 11785495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
